ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/1/2026

1. NKE
2. TSLA
3. SPY
4. BE
5. SPCX
6. META
7. ABVX
8. NVDA
9. STZ
10. MU

Go back to ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer
(NASDAQ: ALXO) Delayed: 2.09 +0.02 (0.97%)
Previous Close $2.07    52 Week High $ 
Open $2.04    52 Week Low $ 
Day High $2.11    P/E N/A 
Day Low $1.98    EPS $ 
Volume 897,059